3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
106
Pancreatic Neoplasms
31
Esophageal Neoplasms
17
Esophageal Squamous Cell Carcinoma
11
Biliary Tract Neoplasms
11
Colorectal Neoplasms
10
Cholangiocarcinoma
6
Neoplasm Metastasis
5
Nasopharyngeal Carcinoma
5
Adenocarcinoma
5
Recurrence
4
Head and Neck Neoplasms
4
Gastrointestinal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Advanced Pancreatic Cancer
3
Advanced Gastric Cancer
3
Stage IV Gastric Cancer With Metastasis
2
Neoplasms
2
NSCLC
2
Locally Advanced Gastric Cancer
2
Gastric Cancer Peritoneal Metastases
2
Gastric Adenocarcinoma
2
Gallbladder Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
mCRC
1
Surgically-Created Resection Cavity
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
nimotuzumab
2
Gemcitabine
2
surufatinib
1
S 1 (combination)
1
Radiofrequency Ablation
1
Oxaliplatin
1
Mass Screening
1
Leucovorin
1
Irinotecan
1
Hematologic Tests
1
Fluorouracil
1
Blood Specimen Collection
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pancreatic cancer, adult
×
S 1 (combination)
×
Clear all
NCT06584227
2025-12-08
ACPC
Jinling Hospital, China
Phase 2
Recruiting
45 enrolled